{
  "catalogId": "b45c21e0-da11-4102-a448-25614dcc6cb7",
  "name": "ONGENTYS 50 MG",
  "status": "",
  "category": "29C",
  "registrationValidity": "valid",
  "registrationNumber": "170 17 37081 99",
  "treatmentDescriptions": "ONGENTYS is indicated as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinsonâ€™s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.",
  "termsOfIssue": "",
  "form": "capsule, hard",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "OPICAPONE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "N04BX04",
      "name": "OPICAPONE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ONGENTYS 25MG CAPSULES",
      "manufacturer": {
        "name": NaN,
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 10.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER OPA/ALU/PVC/ALU",
      "shelfLife": "60",
      "storageConditions": "",
      "codes": {
        "moh": "20883"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": NaN,
        "retailMargin": NaN,
        "maxRetailPrice": NaN,
        "maxPriceWithVAT": NaN
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T15:28:55.979069"
  }
}